These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22200669)

  • 1. Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.
    Sheng XJ; Zhou YQ; Song QY; Zhou DM; Liu QC
    Oncol Rep; 2012 Apr; 27(4):1011-8. PubMed ID: 22200669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
    Zhang S; Lin QD; DI W
    Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
    Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
    Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short hairpin RNA-induced CXCR4 silence on ovarian cancer cell.
    Chen HY; Wang JM; Wang HY; Zhang YX; Liu W; Pan L; Wang WH; Chen SF; Jin WG; Wang L
    Biomed Pharmacother; 2012 Oct; 66(7):549-53. PubMed ID: 22902648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
    Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
    Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
    Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
    Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.
    Al-Alwan M; Olabi S; Ghebeh H; Barhoush E; Tulbah A; Al-Tweigeri T; Ajarim D; Adra C
    PLoS One; 2011; 6(11):e27339. PubMed ID: 22076152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.
    Yang J; Zhang B; Lin Y; Yang Y; Liu X; Lu F
    Cancer Lett; 2008 Sep; 269(1):46-56. PubMed ID: 18502034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
    Baek SH; Kim SM; Nam D; Lee JH; Ahn KS; Choi SH; Kim SH; Shim BS; Chang IM; Ahn KS
    Pharm Biol; 2012 Oct; 50(10):1210-8. PubMed ID: 22853317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis.
    Hurst DR; Edmonds MD; Scott GK; Benz CC; Vaidya KS; Welch DR
    Cancer Res; 2009 Feb; 69(4):1279-83. PubMed ID: 19190326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
    Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
    J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
    Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
    Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
    Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
    Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
    Kong B; Lv ZD; Wang Y; Jin LY; Ding L; Yang ZC
    Int J Clin Exp Pathol; 2015; 8(9):11076-83. PubMed ID: 26617826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
    Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
    Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system.
    Chiaramonte R; Colombo M; Bulfamante G; Falleni M; Tosi D; Garavelli S; De Simone D; Vigolo E; Todoerti K; Neri A; Platonova N
    Int J Biochem Cell Biol; 2015 Sep; 66():134-40. PubMed ID: 26235278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.
    Manu KA; Shanmugam MK; Rajendran P; Li F; Ramachandran L; Hay HS; Kannaiyan R; Swamy SN; Vali S; Kapoor S; Ramesh B; Bist P; Koay ES; Lim LH; Ahn KS; Kumar AP; Sethi G
    Mol Cancer; 2011 Sep; 10():107. PubMed ID: 21880153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
    Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
    Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
    Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.